Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 15Not yet recruiting 9Terminated 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Non-Small-Cell Lung 13Neoplasms 10Melanoma 9Lung Neoplasms 8Breast Neoplasms 8Multiple Myeloma 7Leukemia, Myeloid, Acute 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 5Brain Neoplasms 5Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Carcinoma, Transitional Cell 3Carcinoma, Renal Cell 3Thyroid Neoplasms 2

Interventions

4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Advanced Solid Tumors × 30 days × Clear all
NCT05571969 2026-06-01

Study of PARPi 2X-121 as Monotherapy and in Combination With Dovitinib in Patients With Advanced Solid Tumors

Allarity Therapeutics

Phase 1 Terminated
14 enrolled 20 charts
Other solid neoplasm

Advanced Solid Tumors

NCT05109975 2026-05-28

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

Debiopharm International SA

Phase 1 Terminated
66 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡